Form 4: USANA Health Sciences Chief Scientific Officer Exercises RSUs, Sells Shares for Tax

USANA Health Sciences' Chief Scientific Officer, Kathryn Michelle Armstrong, acquired 1,165 shares of common stock through RSU vesting and subsequently sold 517 shares to cover tax obligations.

Summary

• Kathryn Michelle Armstrong, Chief Scientific Officer of USANA Health Sciences Inc. (USNA), engaged in a transaction involving company stock.
• On July 25, 2025, Armstrong acquired 1,165 shares of USNA common stock through the exercise of Restricted Stock Units (RSUs).
• These RSUs vested 25% on the anniversary of July 25, 2024.
• Concurrently, Armstrong disposed of 517 shares of common stock at a price of $31.95 per share. This disposition was likely to cover tax liabilities associated with the RSU vesting.
• Following these transactions, Armstrong directly beneficially owns 648 shares of common stock and 20,256 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving RSU vesting and a subsequent sale for tax purposes. This is a neutral event, neither significantly positive nor negative for the company's outlook.

Positives

• The exercise of Restricted Stock Units indicates a vesting event, which is a positive for the executive as it converts contingent rights into actual shares.

Negatives

• The sale of 517 shares, while common for tax purposes, reduces the executive's direct equity holding in the company.

Future Outlook

NA

Industry Context

This filing is a routine insider transaction report and does not provide broader industry context or trends. It reflects an individual executive's compensation event rather than a strategic company announcement.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, small-scale insider transaction related to executive compensation, not a strategic shift or large-scale divestment.
• Employees: No direct impact indicated.
• Customers: No direct impact indicated.
• Suppliers: No direct impact indicated.
• Creditors: No direct impact indicated.

Key Dates

Keywords

USANA Health Sciences, USNA, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Stock Sale, Executive Compensation, Kathryn Michelle Armstrong, Chief Scientific Officer